Clinical Study of 18F-FAPI-RGD in Interstitial Lung Disease Associated With Connective Tissue Disease
NCT06143540 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2023-11-24
Summary
The goal of this observational study is to examine clinical utility of 18F-FAPI-RGD PET/CT imaging in evaluating connective tissue disease-associated interstitial lung disease. Participants will undergo clinical evaluation and 18F-FAPI-RGD PET/CT examination.
Conditions
Sponsors & Collaborators
-
Sichuan Provincial People's Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-08-16
- Primary Completion
- 2024-05-31
- Completion
- 2024-07-31
Countries
- China
Study Locations
More Related Trials
-
68Ga-FAPI PET/CT in Patients With Various Fibrotic Disease
NCT04831034 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Clinical Study of 18F -FAPI-RGD in Renal Tumor
NCT05976607 ·Status: COMPLETED
-
99mTc-HFAPI SPECT/CT in Pulmonary Fibrosis
NCT05859763 ·Status: UNKNOWN ·Phase: NA
-
Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated Proteins
NCT05749302 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
FAP-targeting PET/CT for Noninvasive Monitoring of Renal Fibrosis
NCT06563765 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.
NCT06151119 ·Status: RECRUITING
-
68Ga-NOTA-PRGD2 PET/CT in Patients With Lung Injury and Pulmonary Fibrosis
NCT02511197 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
PET Imaging of Fibroblast Activation in Atherosclerosis
NCT06280287 ·Status: RECRUITING
-
68Gallium-FAPI46 PET/CT Imaging in Chronic Inflammatory and Fibrotic Diseases
NCT06275477 ·Status: RECRUITING ·Phase: NA
-
Diagnosis of Metastatic Tumors on 68Ga-FAPI-RGD PET-CT and Radioligand Therapy With 177Lu-FAPI-RGD
NCT06638034 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors Application
NCT06270394 ·Status: COMPLETED ·Phase: NA
-
Characterizing Histiocytosis With 68Ga-FAPI PET/CT
NCT05803629 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Clinical Study of 18F-FAPI-RGD in Breast Tumors
NCT05976620 ·Status: COMPLETED
-
18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study.
NCT06164561 ·Status: RECRUITING
-
18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
NCT02448225 ·Status: COMPLETED ·Phase: PHASE2
-
18F-FAPI PET/CT in Patients With Various Types of Cancer
NCT05810324 ·Status: UNKNOWN ·Phase: NA
-
Advanced Imaging for Pulmonary Fibrosis
NCT06532071 ·Status: RECRUITING ·Phase: PHASE2
-
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
NCT03824535 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of 18F-FAPI-RGD in Ovarian Cancer
NCT06614062 ·Status: COMPLETED
-
Characterizing IgG4-RD With 68Ga-FAPI PET/CT
NCT04125511 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
FAPI-74 PET/CT in Adults With Fibrosis
NCT06413355 ·Status: RECRUITING ·Phase: PHASE1
-
Validation of the Analysis Methodology Behind the Use of Quantitative 18F-FDG PET/CT to Assess Lung Inflammation
NCT03312712 ·Status: UNKNOWN
-
Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis
NCT06940427 ·Status: RECRUITING ·Phase: PHASE2
-
68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG
NCT05543317 ·Status: COMPLETED ·Phase: NA
-
Clinical Application of 18F-PFPN PET Imaging in Diagnosis and Staging of Clear Cell Sarcoma of Soft Tissue
NCT05963035 ·Status: UNKNOWN ·Phase: NA